Conmed Corp. logo

CNMD

Conmed Corp.

$99.99

Earnings Summary

Revenue
$277.19Mn
Net Profits
$-168.29Mn
Net Profit Margins
-60.71%
PE Ratio
49.07

Highlights

Revenue:

Conmed Corp.’s revenue jumped 8.63% since last year same period to $277.19Mn in the Q2 2022. On a quarterly growth basis, Conmed Corp. has generated 14.39% jump in its revenue since last 3-months.

Net Profits:

Conmed Corp.’s net profit fell -1366.3% since last year same period to $-168.29Mn in the Q2 2022. On a quarterly growth basis, Conmed Corp. has generated -1223.81% fall in its net profits since last 3-months.

Net Profit Margins:

Conmed Corp.’s net profit margin fell -1265.66% since last year same period to -60.71% in the Q2 2022. On a quarterly growth basis, Conmed Corp. has generated -1082.47% fall in its net profit margins since last 3-months.

PE Ratio:

Conmed Corp.’s price-to-earnings ratio after this Q2 2022 earnings stands at 49.07.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Conmed Corp. post its latest quarter earnings

EPS Estimate Current Quarter
0.82
EPS Estimate Current Year
0.82

Highlights

EPS Estimate Current Quarter:

Conmed Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a 9.33% jump from last quarter’s estimates.

EPS Estimate Current Year:

Conmed Corp.’s earning per share (EPS) estimates for the current year stand at 0.82.

Key Ratios

Key ratios of the Conmed Corp. post its Q2 2022 earnings

Earning Per Share (EPS)
0.76
Return on Assets (ROA)
0.04
Return on Equity (ROE)
-0.16
Dividend Per Share (DPS)
0.8

Highlights

Earning Per Share (EPS):

Conmed Corp.’s earning per share (EPS) jumped 7.04% since last year same period to 0.76 in the Q2 2022. This indicates that the Conmed Corp. has generated 7.04% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Conmed Corp.’s return on assets (ROA) stands at 0.04.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Conmed Corp.’s return on equity (ROE) stands at -0.16.

Dividend Per Share (DPS):

Conmed Corp. declared 0.8 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-05
0.62
0.7
12.9%
2022-07-28
0.75
0.76
1.33%

Company Information

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.

Organisation
Conmed Corp.
Headquarters
Utica, New York, US
Employees
3.4K
Industry
Health Technology
CEO
Curt Hartman